Zhen Zhang
Fudan University · Shanghai 6th People's Hospital · Xuzhou Central Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
31
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
44 more share only the name and are not shown
Trial papers in colorectal cancer
70
PubMed author-name match
Trials
Studies that name Zhen Zhang as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:52 UTC. Open this list on ClinicalTrials.gov
- Ph3NCT07877597 · Chemotherapy Combined With or Without Short-Course Radiotherapy Versus Chemotherapy Alone as Neoadjuvant Therapy for High-Risk Locally Advanced Colon Cancer With pMMR/MSSFudan University · not yet recruiting · Locally Advanced Colon Cancer, pMMR · principal investigator
- Ph2NCT07183865 · Hypofractionated Radiotherapy Combined With NALIRIF, PD-1 Antibody in Locally Recurrent Rectal Cancer(NOVELTY-R)Fudan University · recruiting · Locally Recurrent Rectal Cancer · principal investigator
- Ph1NCT07178327 · Phase I Clinical Study to Assess Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of LYN101Shanghai TTM-Bio Technology Co., Ltd · active not recruiting · Osteoporotic Fracture · principal investigator
- Ph2NCT07150949 · Long-course Chemoradiotherapy or Short-course Radiotherapy Combined With CAPOX, PD-1antibody, and COX-2 Inhibitor for MSS Locally Advanced Rectal Cancer (SERRAC)Fudan University · recruiting · Locally Advanced Rectal Cancer, Neoadjuvant Therapy · principal investigator
- Ph2NCT06928584 · Hypofractionated Radiotherapy Plus Immunotherapy Versus Conventional Radiotherapy in Locally Recurrent Rectal CancerFudan University · recruiting · Locally Recurrent Rectal Cancer · principal investigator
- Ph2NCT06665087 · CGA Guided Ultrafractionated RT and First-line Systemic Treatment in Elderly or Frail Patients with MCRCFudan University · not yet recruiting · Colon Cancer, Rectal Cancer · principal investigator
- Ph2NCT06652412 · CGA Guided Ultrafractionated RT and Systemic Treatment in Elderly or Frail Patients with Inoperable Localized CRCFudan University · not yet recruiting · Colon Cancer, Rectal Cancer · principal investigator
- Ph2NCT06462053 · Short-course Radiotherapy Combined With CAPOX and PD-1 Antibody Versus Long-course Chemoradiotherapy Combined With CAPOX for Early Low-lying Rectal CancerFudan University · recruiting · Early Low Rectal Cancer · principal investigator
- Ph2NCT06281405 · CAPOX and PD-1 Antibody Combined With or Without Radiotherapy for MSS Locally Advanced Rectal CancerFudan University · recruiting · Locally Advanced Rectal Cancer, Neoadjuvant Therapy · principal investigator
- Ph2NCT05963490 · Regorafenib Alone or in Combination With Hypofractionated/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorectal CancerFudan University · unknown · Microsatellite Stable Metastatic Colorectal Cancer · principal investigator
- Ph1/Ph2NCT05839275 · The Combination of Radiotherapy，Surufatinib and Sintilimab in High-Risk Localized Soft Tissue SarcomaFudan University · recruiting · High-Risk Localized Soft Tissue Sarcoma · principal investigator
- Ph1/Ph2NCT05774275 · The Combination of Radiotherapy, Chemotherapy and Immunotherapy in High-Risk Localized Soft Tissue SarcomaFudan University · recruiting · High-Risk Localized Soft Tissue Sarcoma · principal investigator
- N/ANCT05688033 · Dosimetric Limitation of Pelvic Bone and Peritoneal Space in Rectal Cancer Patients During ChemoradiotherapyFudan University · unknown · Rectal Cancer · principal investigator
- Ph2NCT05628038 · The Combination of Hypofractionated Radiotherapy and Immunotherapy in Locally Recurrent Rectal CancerFudan University · unknown · Recurrent Rectal Cancer · principal investigator
- Ph3NCT05439629 · Efficacy Evaluation Study of BAT5906 and Lucentis® in Patients With Macular DegenerationBio-Thera Solutions · completed · Neovascular (Wet) Age-related Macular Degeneration · principal investigator
- Ph3NCT04997837 · Study of Adjuvant Chemotherapy With or Without PD-1 Inhibitors and Chemoradiotherapy in Resected pN3 Gastric (G) or GEJ AdenocarcinomaFudan University · recruiting · Gastric Cancer · principal investigator
- Ph2NCT04948034 · The Combination of Fruquintinib, Tislelizumab and Stereotactic Ablative Radiotherapy in Metastatic Colorectal Cancer(RIFLE)Fudan University · unknown · Metastatic Colorectal Cancer · principal investigator
- N/ANCT04886778 · Efficacy and Safety of Low-Carbohydrate Diet Combined With Probiotics for Weight Loss in Male Obese Patients.Sun Jia · completed · Obesity · principal investigator
- Ph2NCT04535024 · The Combination of Immunotherapy and Stereotactic Ablative Radiotherapy in MSS Oligometastatic Colorectal CancerFudan University · unknown · Colorectal Cancer · principal investigator
- Ph2NCT04518280 · Short-course Radiotherapy Based TNT Combined With PD-1 Inhibitor for Locally Advanced Rectal CancerFudan University · completed · Locally Advanced Rectal Cancer · principal investigator
- Ph2NCT04499586 · A Study of Radiotherapy Combined With Raltitrexed and Irinotecan in Metastatic or Locally Recurrent Colorectal CancerFudan University · unknown · Recurrent Colorectal Cancer · principal investigator
- Ph2NCT04411524 · The Combination of Immunotherapy and Neoadjuvant Chemoradiotherapy in MSI-H Locally Advanced Rectal CancerFudan University · unknown · Locally Advanced Rectal Cancer · principal investigator
- Ph2NCT04411537 · The Combination of Immunotherapy and Neoadjuvant Chemoradiotherapy in MSS Locally Advanced Rectal CancerFudan University · unknown · Locally Advanced Rectal Cancer · principal investigator
- Ph2NCT04394598 · A Study of Chinese Herbal Compound Dendrobium Huoshanense Granules in NCRT for Patients With Locally Advanced Rectal CancerFudan University · unknown · Locally Advanced Rectal Cancer · principal investigator
- N/ANCT03824899 · UGT1A1 Combined With Pharmacokinetics of SN-38 in CPT-11-based CRT in Patients With Advanced Rectal CancerFudan University · unknown · Locally Advanced Rectal Cancer · principal investigator
- Ph2NCT03823079 · Comparison of Interleukin-11 and rhTPO for Recurrent Colorectal Cancer Patients With ThrombocytopeniaFudan University · unknown · Recurrent Colorectal Carcinoma, Thrombopenia · study chair
- Ph2NCT03702985 · Radiation-protection Effect of Amifostine in Locally Advanced Rectal CancerFudan University · unknown · Locally Advanced Rectal Cancer · principal investigator
- N/ANCT03577808 · Organoids in Predicting Chemoradiation Sensitivity on Rectal CancerZhen Zhang · unknown · Organoids, Rectal Cancer, Chemoradiation · principal investigator
- Ph3NCT03013010 · PREACT Study: Locally Advanced Gastric Cancer, Chemoradiotherapy vs. Chemotherapy Followed by D2 Surgery and Adjuvant ChemotherapyShanghai Cancer Hospital, China · completed · Stomach Neoplasm, GastroEsophageal Cancer, Adenocarcinoma · principal investigator
- Ph3NCT02605265 · Trial of Capecitabine With or Without Irinotecan Driven by UGT1A1Fudan University · completed · Locally Advanced Rectal Cancer · principal investigator
- Ph2NCT02024217 · Neoadjuvant Chemotherapy Plus Chemoradiation in Patients With Potentially Resectable Gastric CarcinomaFudan University · unknown · Gastric Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:52 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 44 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in colorectal cancer, ranked by citations from NIH iCite, fetched 2026-11-12 11:52 UTC. The ranking covers the 200 most relevant of 70 PubMed records, and a shared surname and initials can bring in a namesake. All 70 on PubMed
- 150 citationsRCR 11.7
- p53 nuclear overexpression: an independent predictor of survival in lymph node--positive colorectal cancer patients.J Clin Oncol · 1994138 citationsRCR 3.8
- Randomized Phase II Trial of Immunotherapy-Based Total Neoadjuvant Therapy for Proficient Mismatch Repair or Microsatellite Stable Locally Advanced Rectal Cancer (TORCH).J Clin Oncol · 2024124 citationsRCR 13.8
- 121 citationsRCR 5.3
- Xiao-Chai-Hu-Tang ameliorates tumor growth in cancer comorbid depressive symptoms via modulating gut microbiota-mediated TLR4/MyD88/NF-κB signaling pathway.Phytomedicine · 2021116 citationsRCR 7.3
- 112 citationsRCR 4.7
- 83 citationsRCR 2.7
- Efficacy and safety of PD-1 blockade plus long-course chemoradiotherapy in locally advanced rectal cancer (NECTAR): a multi-center phase 2 study.Signal Transduct Target Ther · 202479 citationsRCR 8.7
- Randomized clinical trial of intravenous soybean oil alone versus soybean oil plus fish oil emulsion after gastrointestinal cancer surgery.Br J Surg · 201069 citationsRCR 2.4
- Concomitant boost IMRT-based neoadjuvant chemoradiotherapy for clinical stage II/III rectal adenocarcinoma: results of a phase II study.Radiat Oncol · 201457 citationsRCR 2.1